Topic prioritisation

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Decision date

Decision date

Prioritisation programme

Prioritisation programme

Decision

Decision

Showing 1 to 8 of 8

TitlePrioritisation programmeDecisionDecision date
Tolebrutinib for treating primary progressive multiple sclerosis [TSID12166]None selectedAwaiting decision
Ocrelizumab for treating relapsing–remitting multiple sclerosis in people 10 to 17 years [TSID12164]None selectedNot selected
Subcutaneous ocrelizumab for treating primary progressive or relapsing multiple sclerosis [TSID11895]None selectedNot selected
Dimethyl fumarate for treating relapsing-remitting multiple sclerosis in people aged 13 to 17 [TSID11778]None selectedNot selected
Natalizumab for treating highly active relapsing-remitting multiple sclerosis [ID4020]None selectedNot selected
Glatiramer acetate depot for multiple sclerosis [TSID10620]None selectedFurther information required
Fingolimod for treating relapsing multiple sclerosis in children and young people [ID1378]None selectedNot selected
Autologous unmanipulated peripheral blood stem cell therapy for multiple sclerosisNone selectedFurther information required

Results per page

  1. 10
  2. 25
  3. 50
  4. All